| Issue |
Title |
File |
| Vol 11, No 1 (2025) |
Methodological recommendations (draft). Systemic lupus erythematosus: Diagnosis, treatment, monitoring (short version) |
|
|
Popkova Т.V., Panafidina T.A., Lila A.M.
|
| No S1 (2022) |
Metody bal'neo- i fizioterapii v meditsinskoy reabilitatsii bol'nykh s zabolevaniyami sustavov, oslozhnennykh povyshennoy meteochuvstvitel'nost'yu |
|
|
Uyanaeva A.I., Tupitsyna Y.Y., L'vova N.V., Lyamina N.P., Ksenofontova I.V.
|
| Vol 9, No 2 (2023) |
MicroRNA-1 and microRNA-133: Small molecules of great importance in the aspect of cardiovascular diseases |
|
|
Aliyeva A.M., Teplova N.V., Butenko A.V., Averin E.E., Akhmedova M.F., Shikhova Y.A., Valiev R.K., Sariyev M.N., Kotikova I.A., Nikitin I.G.
|
| Vol 7, No 5 (2021) |
Mild cognitive impairment in clinical practice |
|
|
Bogolepova A.N.
|
| Vol 7, No 8 (2021) |
Mild forms of COVID-19: the clinical course features in patients with chronic obstructive pulmonary disease |
|
|
Ladnov D.V., Kulik V.V., Kirpichnikov S.I., Shaporova N.L.
|
| Vol 9, No 10 (2023) |
Mineral density bone tissue disorder in case of inflammatory bowel diseases (literature review) |
|
|
Abdulganieva D.I., Kupkenova L.M., Yangurazova A.R., Myasoutova E.R.
|
| No 7 (2017) |
Miofascial pulmonary syndrome: topical aspects of treatment at the phase of primary health care |
|
|
Trukhan D.I., Degovtsov E.N.
|
| Vol 9, No 2 (2023) |
Mixed infection with hepatitis A and E in combination with hemorrhagic fever with renal syndrome |
|
|
Shiryaeva M.A., Lebedeva N.N., Baranov A.E., Agarkova A.A., Malinnikova E.Y.
|
| No S1 (2022) |
Mobil'noe prilozhenie dlya otsenki prognoza u bol'nykh khronicheskoy serdechnoy nedostatochnost'yu s uchetom funktsional'nogo sostoyaniya pochek |
|
|
Kamilova U.K., Masharipova D.R., Tagaeva D.R., Abdullaeva C.A., Beknazarova S.S., Ikramova F.A.
|
| No 6 (2017) |
Modelling of parameters lipid a spectrum depending on age and size of an index of weight of a body at patients with clinical forms of ischemic illness of heart |
|
|
Fishman B.B., Khorochevskaya A.I., Zurabov V.V., Savolyuk A.V., Zhbanova N.O., Butrimova S.S., Prozorova I.V., Shamiladze D.A., Lole O.Y.
|
| Vol 7, No 7 (2021) |
Models of risk determination of cancer-associated thromboses |
|
|
Tarasova L.V., Dimitrieva O.V., Dolgov I.Y., Elmurzayeva A.A.
|
| Vol 8, No 2 (2022) |
MODERN ALGORITHM FOR THE TREATMENT OF OSTEOARTHRITIS |
|
|
LILA A.M., ALEKSEEVA L.I., TASKINA E.A., KASHEVAROVA N.G.
|
| No 7-8 (2018) |
Modern approach to the diagnosis and treatment of anxiety disorders |
|
|
Korabelnikova E.A.
|
| Vol 9, No 8 (2023) |
Modern approaches to colorectal cancer screening and prevention |
|
|
Bakulin I.G., Zharkov A.V., Serkova M.Y., Zhuravleva M.S.
|
| Vol 11, No 2 (2025) |
Modern approaches to the diagnosis and treatment of sarcopenia in patients with chronic kidney disease |
|
|
Gasanov M.Z., Batyushin M.M., Veber V.R., Chulkov V.S., Azovtseva O.V.
|
| No 1 (2017) |
Modern approaches to the treatment of patients with acute tonsillopharyngitis |
|
|
Edzhe M.A., Ovchinnikov A.Y., Khon Y.M.
|
| No 1 (2017) |
Modern aspects of diagnosis and treatment of chi heart failure: what’s new? |
|
|
Shaposhnik I.I.
|
| Vol 9, No 8 (2023) |
Modern aspects of the use of acetylsalicylic acid in pregnant women |
|
|
Chulkov V.S., Nikolenko E.S., Chulkov V.S., Okonenko T.I., Zhmaylova S.V.
|
| Vol 9, No 2 (2023) |
Modern aspects of the use of local hyaluronic acid in musculoskeletal diseases |
|
|
Strebkova E.A., Alekseeva L.I.
|
| Vol 9, No 8 (2023) |
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors |
|
|
Usanova A.A., Lavrenova E.A., Kunyaeva T.A., Kuzma F., Novikova E.K., Sergutova N.P., Chatkina T.A.
|
| No 5 (2018) |
Modern capacities of the control of early carbohydrate metabolism disorders |
|
|
Demidova T.J., Ushanova F.O.
|
| Vol 9, No 4 (2023) |
Modern concepts concerning the mechanisms of iron absorption: activators, inhibitors, regulation, new possibilities of optimization |
|
|
Stuklov N.I., Gurkina A.A., Kovalchuk M.S., Kisly N.D.
|
| Vol 11, No 3 (2025) |
Modern concepts of pleiotropic effects of semaglutide in a wide population of patients |
|
|
Demidova T.Y., Teplova A.S., Izmailova M.Y.
|
| No 4 (2016) |
Modern facilities and future prospects in pharmacotherapy of obesity |
|
|
Demidova T.Y., Stelmakh M.V.
|
| No 8 (2017) |
MODERN MARKER OF RENAL DYSFUNCTION |
|
|
Muchtarov T.A., Skvortsov V.V.
|
| No 3 (2017) |
Modern methods of rehabilitation of patients with irritable bowel syndrome |
|
|
Akhmedov V.A., Orlov I.N., Gaus O.V.
|
| Vol 10, No 1 (2024) |
Modern methods of surgical treatment of patients with rheumatic diseases |
|
|
Makarov M.A., Roskidailo A.A.
|
| Vol 10, No 8 (2024) |
Modern opportunities for residual cardiovascular risk reducing |
|
|
Boeva O.I., Rzhevskaya E.V., Shkuta E.V., Baibuldin I.R., Drozdov V.V., Puchkova E.Y.
|
| Vol 9, No 4 (2023) |
Modern opportunities for treatment of patient having chronic heart failure with low ejection fraction |
|
|
Roitberg G.E., Ardashev A.V., Zhelyakov E.G., Kondratova N.V., Merzyavko L.K., Ponkina N.K., Slastnikova I.D., Sokolov D.V.
|
| No 1 (2017) |
Modern potentials for use of candesartan in prevention and treatment of cardiovascular diseas |
|
|
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Yevstigneeva A.S.
|
| Vol 7, No 5 (2021) |
Modern principles of management of a patient with acute dorsalgia |
|
|
Kamchatnov P.R., Chugunov A.V., Ashalmagomedova Z.A., Shemshedinova A.M.
|
| Vol 7, No 10 (2021) |
Modern principles of osteoporosis therapy |
|
|
Zhugrova E.S., Mazurov V.I.
|
| Vol 11, No 1 (2025) |
Modern proton pump inhibitors: clinical advantages of esomeprazole |
|
|
Ketova G.G., Shamina O.M., Dolgushina A.I.
|
| Vol 9, No 5 (2023) |
Modern strategies for safety of iron deficiency pharmacotherapy improving |
|
|
Shikh E.V., Makhova A.A., Krasnoperova E.V.
|
| Vol 7, No 8 (2021) |
Modern strategy of anti-ischemic therapy for patients with chronic coronary syndromes |
|
|
Lyamina N.P.
|
| Vol 7, No 8 (2021) |
Modern strategy of diagnosis and therapy of patients with obstructive sleep apnea |
|
|
Babak S.L., Budnevsky A.V., Buzunov R.V.
|
| No 2 (2017) |
Modern technology of training as a method of improving the quality of treatment and diagnostics of comorbid patients |
|
|
Arutyunov G.P., Dragunov D.O., Sokolova A.V., Simbirtseva S.Y., Palferova Y.A.
|
| Vol 8, No 1 (2022) |
Modern treatment of bronchial asthma |
|
|
Emelyanov A.V., Leshenkova E.V., Sergeeva G.R., Tsukanova I.V.
|
| Vol 9, No 9 (2023) |
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening |
|
|
Larina V.N., Lankin A.O., Larin V.G., Golovko M.G.
|
| No 1 (2016) |
MODES OF ANTIMICROBIAL THERAPY AND PREVENTION OF EXACERBATIONS OF CHRONIC BRONCHITIS / CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
|
|
Zaitsev A.A., Kryukov Y.V.
|
| No 5 (2017) |
Molecular mechanisms of action of Laennec against development of metabolic syndrome and obesity |
|
|
Gromova O.A., Torshin I.Y., Zgoda V.G., Tomilova I.K.
|
| No 4 (2015) |
MOLECULAR MECHANISMS OF BODY WEIGHT REGULATION AS TARGETS FOR PATHOGENETIC THERAPY OF OBESITY |
|
|
Romantsova T.I.
|
| No S1 (2022) |
Molekulyarno-geneticheskie prediktory razvitiya i progressirovaniya antratsiklin-indutsirovannoy kardiotoksichnosti |
|
|
Kop'eva K.V.
|
| No 7-8 (2018) |
Monitoring of the quality of thrombolytic therapy in case of acute coronary syndrome at pre-hospital stage |
|
|
Khusainova D.F., Kholkin I.V., Sokolova L.A.
|
| No S1 (2022) |
Monitoring rannikh narusheniy obmena kholesterina |
|
|
Pavlova V.Y., Boyko E.A.
|
| Vol 7, No 6 (2021) |
Monitoring the dynamics of behavioral risk factors in patients with angina pectoris and comorbid condition |
|
|
Didigova R.T., Evloeva D.A., Ugurchieva Z.O., Ugurchieva P.O., Malsagova I.Y.
|
| Vol 9, No 8 (2023) |
More on the neuroprotectory therapy evidential base: focus at ethylmethyl hydroxypyridine succinate |
|
|
Kochetkov A.I., Shatalova N.A., Klepikova M.V., Filippova T.V., Ostroumova O.D.
|
| No S1 (2022) |
Mozhno li dietoy regulirovat' autofagiyu u cheloveka |
|
|
Tkhakushinov I.A.
|
| No S1 (2022) |
Mozhno li schitat' povyshennye pokazateli okruzhnosti talii i okruzhnosti beder, sootnosheniya okruzhnosti talii k okruzhnosti beder, insulinopodobnogo faktora rosta-1 prediktorami follikulyarnoy adenomy shchitovidnoy zhelezy? |
|
|
Khalimova A.S., Kvitkova L.V.
|
| Vol 7, No 10 (2021) |
Mucins and carbocisteine: respiratory protection |
|
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
|
| Vol 10, No 6 (2024) |
Mucoactive drugs in the treatment of patients with acute and chronic respiratory pathology |
|
|
Prozorova G.G., Budnevsky A.V., Chernik T.A.
|
| Vol 8, No 2 (2022) |
MULTICENTER PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF THE COMBINED USE OF GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX AND DIACEREIN IN PATIENTS WITH KNEE OSTEOARTHRITIS |
|
|
ALEKSEEVA L.I., LILA A.M., SHARAPOVA E.P., TASKINA E.A., KASHEVAROVA N.G., STREBKOVA E.A., MAZUROV V.I., ZONOVA E.V., OTTEVA E.N., YAKUPOVA S.P., VINOGRADOVA I.B.
|
| Vol 8, No 3 (2022) |
Multisystem inflammatory syndrome in adults associated with COVID-19 |
|
|
Bolieva L.Z., Malyavin A.G., Aidarova N.K., Byazrova S.S.
|
| Vol 7, No 7 (2021) |
Musculoskeletal manifestations and prevalence of orthopedic pathology: clinical and diagnostic significance in case of joint hypermobility syndrome |
|
|
Saneeva G.A.
|
| No S1 (2022) |
Muzhchiny molodogo vozrasta s infarktom miokarda i fenomenom zamedlennogo koronarnogo krovotoka: god posle indeksnogo sobytiya |
|
|
Tkachenko V.V., Karpunina N.S.
|
| No S1 (2022) |
Myocardial infarction and what precedes it |
|
|
Trofimov S.V., Trofimova L.A., Busalaeva E.I., Vasilieva N.P.
|
| Vol 9, No 4 (2023) |
Myocardial infarction in young men: androgen levels and predictors of post-hospital adverse cardiovascular events |
|
|
Tkachenko V.V., Tuev A.V., Karpunina N.S., Shishkina E.A.
|
| Vol 9, No 4 (2023) |
Myocardial infarction type 1 at young age: contribution of proatherogenic factors and genetic thrombophilies |
|
|
Shushanova A.S., Gladkikh N.N., Yagoda A.V.
|
| No 2 (2015) |
National guidelines for the diagnosis and treatment of acid-related and associated with Helicobacter pylori diseases (V Moscow agreement) |
|
|
- -.
|
| No S1 (2022) |
NDST kak faktor riska razvitiya psikhovegetativnykh rasstroystv i khronicheskoy ishemii golovnogo mozga u lits molodogo vozrasta |
|
|
Mal'tseva I.V., Lomakina N.A.
|
| No S1 (2022) |
Nealkogol'naya zhirovaya bolezn' pecheni i metabolicheskiy sindrom u lits molodogo vozrasta |
|
|
Pankova E.D.
|
| Vol 8, No 5 (2022) |
Nebulized budesonide in asthma exacerbations: rules of therapy in the COVID-19 era |
|
|
Babak S.L., Gorbunova M.V., Goruleva E.I., Malyavin A.G.
|
| No 2 (2016) |
NECK PAIN: POSSIBILITY OF TREATMENT |
|
|
KOTOVA O.V., AKARACHKOVA E.S.
|
| No S1 (2022) |
Nekotorye aspekty patogeneza immunovospalitel'nykh zabolevaniy |
|
|
Shilkina N.P., Dryazhenkova I.V., Yunonin I.E., Chetvertakova Z.E.
|
| No S1 (2022) |
Nemedikamentoznoe vosstanovlenie ritma stula s pomoshch'yu natural'noy mineral'noy vody u molodykh i pozhilykh patsientov |
|
|
Shemerovskiy K.A., Kantemirova R.K., Seliverstov P.V., Vasil'ev V.V.
|
| Vol 8, No 9 (2022) |
NEUROINFLAMMATION AND THROMBOINFLAMMATION IN CEREBROVASCULAR DISEASE AND VASCULAR COGNITIVE IMPAIRMENT |
|
|
Koltsov I.A., Shchukin I.A., Chubykin V.I., Fidler M.S.
|
| Vol 8, No 3 (2022) |
Neurological aspects of the postcovide syndrome |
|
|
Kamchatnov P.R., Khanmurzayeva S.B., Chugunov A.V., Khanmurzayeva N.B.
|
| Vol 8, No 1 (2022) |
Neurological manifestations of post-covid syndrome |
|
|
Zakharov V.V., Gromova D.O.
|
| Vol 8, No 7 (2022) |
Neuropsychiatric disorders of non-alcoholic fatty liver disease |
|
|
Prikhodko V.A., Okovity S.V.
|
| Vol 9, No 10 (2023) |
Neurorehabilitation after a stroke: what a therapist should know |
|
|
Shishkova V.N., Shishkov V.A.
|
| Vol 8, No 5 (2022) |
New criteria for long-term CPAP therapy adherence in obstructive sleep apnea syndrome and arterial hypertension patients |
|
|
Ovchinnikov Y.V., Mostovoy L.V., Zaitsev A.A.
|
| No 2 (2017) |
New data on safety of NSAIDs: concept of the «class-specific» high cardiovascular risk of selective COX-2 inhibitors got out of date |
|
|
Karateev A.Y., Nasonov Y.L., Novikova D.S.
|
| No 4S (2022): Supplement |
New diagnostic capabilities of the 6-minute walk test in COPD patients |
|
|
Babkin A.P.
|
| Vol 10, No 9 (2024) |
New horizons in managing dyslipidemia – a risk factor for cardiovascular diseases |
|
|
Usanova A.A., Novikova E.K., Sergutova N.P., Kuzma F.M., Vasilkova A.S.
|
| Vol 9, No 4 (2023) |
New opportunities for chronic heart failure patients’ treatment: focus at dapagliflosin |
|
|
Malimon V.V., Kokorin V.A.
|
| Vol 7, No 6 (2021) |
New perspectives and real possibilities in the treatment of patients with heart failure |
|
|
Shulkina S.G., Kokorin V.A.
|
| No 3 (2018) |
New possibilities for personalizing prognosis in patients with nonvalvular atrial fibrillation |
|
|
Agibova N.E., Boeva O.I.
|
| No 1 (2018) |
New possibilities of artificial intelligence method applications for to simulate the occurrence and development of diseases and optimize their prevention and treatment |
|
|
Yasnitsky L.N., Dumler A.A., Cherepanov F.M.
|
| Vol 8, No 2 (2022) |
NEW POSSIBILITIES OF LOCAL INJECTION THERAPY IN COMPLEX TREATMENT OF SKELETAL AND MUSCULAR PAIN |
|
|
NESTERENKO V.A., KARATEEV A.E.
|
| No 3 (2015) |
NEW POSSIBILITIES OF PHARMACOLOGICAL CARDIOVERSION OF NEWLY DEVELOPED PAROXYSM OF ATRIAL FIBRILLATION |
|
|
Cheltsov V.V., Guschina Y.S., Illarionova T.S., Korovyakova E.A., Martynov A.I.
|
| No 7-8 (2018) |
New possibilities of uratedecreasing therapy in patients with arthrolithiasis |
|
|
Petrova M.S., Musiichuk M.M., Inamova O.V., Mazurov V.I.
|
| No 1 (2018) |
New strategy of mucolytic therapy in modern medical practice |
|
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
|
| Vol 10, No 8 (2024) |
New therapeutic opportunities of gastroprotection in cardiology |
|
|
Golendyaeva P.I., Livzan M.A., Korennova O.Y., Gaus O.V., Podolnaya S.P., Shkirinets A.V., Shukil L.V., Maltsev S.N.
|
| No 4S (2022): Supplement |
New ways for diagnostics of non-specific ulcerative colitis |
|
|
Lagutina S.N., Zuikova A.A., Dobrynina I.S., Kotova Y.A.
|
| No 5 (2018) |
News of clinical recommendations on diagnostics and treatment of subclinical hypothyroidism in pregnant women |
|
|
Demidova T.J., Balutina O.V., Gritzkevich E.J.
|
| No S1 (2022) |
Nizkaya predtestovaya veroyatnost' ishemicheskoy bolezni serdtsa: analiz faktorov riska |
|
|
Roytberg G.E., Slastnikova I.D., Davydova A.S.
|
| No 3 (2017) |
Nolodotak (flupirtine) in treatment of patients with dorsopathy |
|
|
Kamchatnov P.R., Khanmurzaeva N.B., Khanmurzaeva S.B.
|
| Vol 7, No 7 (2021) |
Non-alcoholic fatty liver disease and atherosclerosis: common mechanisms of development and progression |
|
|
Kuznetsova A.S., Genkel V.V., Dolgushina A.I., Shaposhnik I.I., Olevskaya E.R., Selyanina A.A., Khusainova G.M.
|
| Vol 7, No 7 (2021) |
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version) |
|
|
Lazebnik L.B.
|
| No 2 (2016) |
Nonalcoholic fatty liver disease: clinic, diagnostics, treatment |
|
|
- -.
|
| No 3 (2017) |
Nonalcoholic fatty liver disease: clinic, diagnostics, treatment (guidelines for the specialists on internal medicine, 2nd version) |
|
|
Lazebnik L.B., Radchenko V.G., Golovanova Y.V., Zvenigorodskaya L.A., Konev Y.V., Seliverstov P.V., Sitkin S.I., Tkachenko Y.I., Avalueva Y.B., Ailamazyan E.K., Vlasov N.N., Grinevich V.B., Kornienko Y.A., Novikov V.P., Khoroshinina L.P., Zhestkova N.V., Oreshko L.S., Dudanova O.P., Dobritsa V.P., Turieva L.V., Tirikova O.V., Kozlova N.M., Yeliseev S.M., Gumerov R.R., Ventsak Y.V., Aleshina Y.I., Gurova M.M., Goryacheva L.G.
|
| Vol 8, No 6 (2022) |
Non-drug methods of treatment in pulmonology |
|
|
Prozorova G.G., Fateeva O.V., Tribuntseva L.V., Kozhevnikova S.A., Olysheva I.A.
|
| Vol 8, No 7 (2022) |
Non-invasive assessment of liver abnormalities in patients with psoriatic arthritis |
|
|
Mukhametshina E.I., Kirillova E.R., Fairushina I.F., Abdulganieva D.I.
|
| Vol 9, No 5 (2023) |
Non-steroid anti-inflammatory drugs in musculoskeletal pain syndrome therapy: Aspects of their effective and safe use |
|
|
Dronova Y.M., Mubarakshina O.A., Chernov S.Y.
|
| Vol 10, No 1 (2024) |
Nonsteroidal anti-inflammatory drugs in therapeutical practice |
|
|
Karateev A.E.
|
| No S1 (2022) |
Novaya koronavirusnaya infektsiya COVID-19, oslozhnennaya razvitiem bystroprogressiruyushchego glomerulonefrita s obrazovaniem antitel k glomerulyarnoy bazal'noy membrane |
|
|
Navaznov V.V., Tasoeva E.S., Karpova S.N., Pavlov A.I., Prokhorchik A.A., Gulyaev N.I., Baksheev V.I.
|
| Vol 8, No 8 (2022) |
Novel coronavirus infection COVID-19: nutritional support from the beginning of the disease to rehabilitation |
|
|
Sirota A.E., Pasechnik I.N., Novikova T.V.
|
| No S1 (2022) |
Novye podkhody k optimizatsii terapii professional'noy bronkhial'noy astmy s fiksirovannoy bronkhial'noy obstruktsiey |
|
|
Artemova L.V., Rumyantseva O.I., Petrykina M.V.
|
| Vol 10, No 3 (2024) |
NSAIDs gastropathies in clinician’s practice |
|
|
Bakulin I.G., Avalueva E.B., Bakulina N.V., Serkova M.Y., Berest D.G., Pavlova E.Y.
|
| No S1 (2022) |
O vzaimosvyazi klinicheskikh proyavleniy postinfektsionnogo glomerulonefrita s funtsional'nym sostoyaniem shchitovidnoy zhelezy |
|
|
Kudryashov S.I.
|
| 801 - 900 of 1554 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 > >> |
